News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mandelia Ashish
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/18/2023 |
4
| Mandelia Ashish (VP, Controller) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 3,575 shares
@ $5.74, valued at
$20.5k
Granted 47,625 options to buy
@ $6.06, valued at
$288.6k
Granted 10,583 restricted stock units
@ $0
Exercised 4,784 restricted stock units
@ $0
Exercised 4,519 restricted stock units
@ $0
Exercised 833 restricted stock units
@ $0 |
|
| 01/19/2022 |
4
| Mandelia Ashish (VP, Controller) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Sold 1,982 shares
@ $5.92, valued at
$11.7k
Exercised 833 restricted stock units
@ $0
Exercised 4,520 restricted stock units
@ $0
Granted 28,700 options to buy
@ $6.28, valued at
$180.2k
Granted 19,133 restricted stock units
@ $0 |
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2020 |
4
| Mandelia Ashish (VP, Controller) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $6.16, valued at
$92.4k
Granted 3,333 restricted stock units
@ $0 |
|
|
|